沙丁胺醇、地塞米松雾化吸入治疗小儿喘息型支气管炎的疗效比较  

The Efficacy Comparison of Albuterol and Dexamethason on the Treatment of Infant Asthmatic Bronchitis by Inhalation

作　　者：陈群英[1] 

机构地区：[1]四川省林业中心医院儿科,四川成都610081

出　　处：《中国医药指南》2012年第19期83-84,共2页Guide of China Medicine

摘　　要：目的对比评价雾化吸入沙丁胺醇、地塞米松对喘息型支气管炎患儿的临床疗效。方法 96例喘息型支气管炎患儿随机分为A组(n=48)和B组(n=48),给予A组患儿沙丁胺醇雾化吸入治疗,B组患儿接受地塞米松雾化吸入治疗,对比两组治疗效果。结果 A组总有效率95.8%(46/48),B组总有效率81.3%(39/48),两组有显著性差异(P<0.05)。结论沙丁胺醇雾化吸入治疗小儿喘息型支气管炎效果显著、安全。Objective To compare the clinical effects of albuterol and dexamethason on the treatment of infant asthmatic bronchitis by inhalation. Method 96 infant asthmatic bronchitis were divided into the A group （n=48） and the B group （n=48） . The A group took albuterol inhalation while the B group took dexamethason inhalation. The clinical effects were measured. Results The total effective rate of the A group was 95.8% and 81.3% of the B group. There was significant different betweeia the two group （P〈0.05） . Conclusion Dexamethason has obvious benefit on the treatment of infant asthmatic bronchitis by inhalation.

关 键 词：喘息型支气管炎 婴幼儿 沙丁胺醇 地塞米松 雾化吸入 

分 类 号：R725.6[医药卫生—儿科]